Key result
Accurate histopathological diagnosis of intrathoracic sarcomas is crucial, often requiring immunohistochemistry and molecular genetic techniques to differentiate from other neoplasms.
Accurate histopathological diagnosis using immunohistochemistry and molecular genetics is crucial for the correct management and prognostication of rare intrathoracic sarcomas.
Emphasizes specialized pathology review for suspected intrathoracic sarcomas; leaves open standardized molecular diagnostic algorithms.
Primary intrathoracic sarcomas constitute a rare, heterogeneous group of neoplasms that occur in the lung parenchyma, pleura, and mediastinum. Although pathologically diverse, they frequently show similar clinical and radiological features, and accurate histopathological diagnosis is therefore crucial for correct management and prognostication. The characterization of sarcomas can be difficult, as there is frequent overlap between the histological patterns of benign and malignant lesions, and between different malignant tumours and with non-mesenchymal neoplasms. This is particularly critical within the thorax, where many spindle cell neoplasms represent tumours of epithelial origin or metastatic disease. Immunohistochemistry and molecular genetic techniques are important ancillary contributors to histological interpretation, but several groups of tumours still lack reliable immunohistochemical markers or reproducible genetic changes. We review the pathology of the major types of intrathoracic sarcoma with reference to clinical factors, morphology, immunohistochemistry, and molecular genetics.
No takes yet. Share an insight, caveat, or question.
Thway et al. (2015) conducted a review in Intrathoracic sarcomas. Accurate histopathological diagnosis of intrathoracic sarcomas is crucial, often requiring immunohistochemistry and molecular genetic techniques to differentiate from other neoplasms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: